501 related articles for article (PubMed ID: 12421226)
61. Hepatitis C virus RNA positivity among RIBA-3 indeterminates.
Jha J; Arankalle VA; Banerjee K
Vox Sang; 1995; 69(2):145-6. PubMed ID: 8585200
[No Abstract] [Full Text] [Related]
62. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors.
Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Kasahara A; Fusamoto H; Ohtani S; Okubo Y; Kamada T
Vox Sang; 1994; 67(3):280-5. PubMed ID: 7532341
[TBL] [Abstract][Full Text] [Related]
63. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape--comparison of screening tests and PCR.
Tucker TJ; Voigt M; Bird A; Robson S; Gibbs B; Kannemeyer J; Galloway M; Kirsch RE; Smuts H
S Afr Med J; 1997 May; 87(5):603-5. PubMed ID: 9254818
[TBL] [Abstract][Full Text] [Related]
64. Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor.
Fang CT; Tobler LH; Haesche C; Busch MP; Phelps B; Leparc G
Transfusion; 2003 Apr; 43(4):541-4. PubMed ID: 12662289
[TBL] [Abstract][Full Text] [Related]
65. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
66. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
[TBL] [Abstract][Full Text] [Related]
67. Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with normal alanine aminotransferase.
Ali N; Moinuddin ; Ahmed SA; Chotani RA; Fisher-Hoch SP
J Coll Physicians Surg Pak; 2010 Oct; 20(10):662-6. PubMed ID: 20943108
[TBL] [Abstract][Full Text] [Related]
68. Use and interpretation of HCV diagnostic tests in the clinical setting.
Gretch DR
Clin Liver Dis; 1997 Nov; 1(3):543-57, vi. PubMed ID: 15560057
[TBL] [Abstract][Full Text] [Related]
69. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
[TBL] [Abstract][Full Text] [Related]
70. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.
Cano H; Candela MJ; Lozano ML; Vicente V
Transfus Med; 2003 Oct; 13(5):259-66. PubMed ID: 14617336
[TBL] [Abstract][Full Text] [Related]
71. Confirmation of hepatitis C virus antibody in blood donors.
Dow BC; Coote I; Munro H; McOmish F; Yap PL; Simmonds P; Follett EA
J Med Virol; 1993 Nov; 41(3):215-20. PubMed ID: 7505306
[TBL] [Abstract][Full Text] [Related]
72. Detection of hepatitis C virus (HCV) core-specific antibody suggests occult HCV infection among blood donors.
Quiroga JA; Avellón A; Bartolomé J; Andréu M; Flores E; González MI; González R; Pérez S; Richart LA; Castillo I; Alcover J; Palacios R; Carreño V; Echevarría JM
Transfusion; 2016 Jul; 56(7):1883-90. PubMed ID: 27185049
[TBL] [Abstract][Full Text] [Related]
73. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
[TBL] [Abstract][Full Text] [Related]
74. [Screening for HCV core antigen among HIV-positive patients infected by sexual transmission].
Dubrous P; Hugard L; Terrier F
Med Mal Infect; 2004 May; 34(5):236-8. PubMed ID: 16235605
[No Abstract] [Full Text] [Related]
75. Testing for HCV markers.
Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
[TBL] [Abstract][Full Text] [Related]
77. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
78. Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood.
Tobler LH; Dockter J; Stramer SL; Kleinman SH; Todd D; Giachetti C; Busch MP
Transfusion; 2002 Nov; 42(11):1525-7. PubMed ID: 12421231
[No Abstract] [Full Text] [Related]
79. Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?
Rowan BP; Smith A; Gleeson D; Hunt LP; Warnes TW
Gut; 1994 Apr; 35(4):542-6. PubMed ID: 8174994
[TBL] [Abstract][Full Text] [Related]
80. HCV antibodies in Hungarian blood donations. Experiences collected by ELISA tests, immunoblot assays and polymerase chain reaction and protocols for donor management.
Héjjas M; Medgyesi GA; Falus A; Hajnal A; Forster T; Szabó J
Transfus Med; 1994 Dec; 4(4):273-80. PubMed ID: 7534174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
